messag updat model elanco kindr phibro petiq zoeti follow respect earn
releas last week chang gener account slow sale due relat disrupt though note
compani benefit due higher on-line altern channel util also adjust pt
model updat revenu project
respect compar street respect
move adj ep estim compar
street estim respect note includ bayer bayn de
nc ah model
model updat revenu estim
respect vs consensu estim respect
model bring revenu vs consensu
updat ep
vs consensu
model model fy end june fy revenu estim
previous vs consensu revenu estim model fy
end june fy adj ep estim respect
vs consensu adj ep estim respect
model updat revenu estim
respect vs consensu estim respect updat
adj ebitda estim vs consensu estim
page analyst certif import disclosur
model updat revenu number
respect compar consensu estim
updat adjust ep estim respect
compar consensu estim
valuat risk
valuat elanco trade adj ep estim approxim discount zoeti
trade adj ep estim although believ elanco oper margin expans potenti think
elanco product mix heavier mfa product anim gener lower lt growth oper margin potenti
maintain neutral rate
upsid risk margin expand quicker investor expect credelio get meaning market share flea tick
categori interceptor meaning take share nexgard versu trifexi mfa-rel headwind subsid pipelin
actual robust near term investor believ
downsid risk gener competit credelio gallipr growth moder margin expans goal achiev risk
includ product recal regulatori risk execut risk currenc personnel risk
valuat current trade ebitda estim ev/ebitda basi although signific
premium entir anim health group believ premium valuat understand given growth potenti abil
scale intern new product invest come fruition howev would look come bit
potenti becom construct maintain neutral rate
downsid risk distributor risk reput risk spend strategi risk increas competit regulatori stock price
valuat use ev/sal revenu estim still get fair valu estim round
multipl reflect compani current statu develop stage compani ad risk busi
develop vs commerci stage compani comp univers includ us european ah pharma compani
maintain neutral rate
upsid risk strong partnership strateg partnership equin new partnership parvo epocat compani
acquir
downsid risk pipeline/develop risk inabl commerci regulatori risk volatil via move line biotech macro
dilut distributor risk issu acquisitions/partnership
page analyst certif import disclosur
valuat although like phibro current trade discount peer cy consensu ev/ebitda vs
product anim peer would remain sidelin pend clariti phibro invest new product drive
growth back level peer elanco zoeti maintain neutral rate
upsid risk unexpect margin expans new product vaccin speedi recoveri dairi price rebound mia/mfa
acquisit companion anim product
downsid risk squeez mfa lot mia abroad like arent estim current polit turmoil exposur
commod macro consum tast consum activ phibro product genet engin could decreas necess
product
valuat use multipl adj ebitda estim arriv pt
averag consensu ev/ebitda multipl companion anim consum anim health group believ
petiq sit halfway consum pet compani consum anim health compani chang price target larg reflect
chang valuat comp group
risk custom concentr risk get credit anim hospit slow growth rate direct sourc relationship
retail direct sourc manufactur hit ebitda margin
valuat use multipl chang adj ep estim arriv pt
multipl repres near-peak trade multipl assum hold comfort given confid
abil compani util tripl pain medic contribut growth beyond
expand margin
page analyst certif import disclosur
page analyst certif import disclosur
good sold
sale market
research develop
gener administr
interest inc exp
incom tax
good sold
research develop
sale market
gener administr
incom tax
good sold
research develop
sale market
gener administr
incom tax
page analyst certif import disclosur
good sold
sale market
incom oper
total incom interest
chang unreal gain lose avaliable-for-sal secur
depreci amort
good sold
sale market
incom oper
depreci amort
good sold
sale market
incom oper
depreci amort
page analyst certif import disclosur
total revenu million dollar
dilut share count million
total revenu million dollar
page analyst certif import disclosur
